(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. TGFß, BMP and insulin mediated differentiation of mesoangioblasts. (a,b) Schematic representation of the TGFß/BMP (a) and insulin (b) signalling pathways in mesoangioblasts: the colour codes indicate the abundance of the different pathway components, ranging from red (highly expressed) to pale red to orange to yellow (poorly expressed); white: not in the array. (c) Western blot analysis of cell lysates from mesoangioblasts treated or untreated (C) with TGFß1, BMP2, or insulin; antibodies against TGFßRI, TGFßRII, BMPR1A, Smad1, Smad2/3, or IGF1Rß were used. (d) Histogram representing the percentage of mesoangioblasts staining Red Oil positive, after treatment with insulin-containing medium. (e-g) Immunofluorescence analysis of mesoangioblasts treated with TGFß1 and stained with antibodies against smooth muscle
-actin (
SMA; e), SM22 (f), calponin 1 (g) and smooth muscle myosin (SM-MyoHC; h) (all in green), merged with DAPI-stained nuclei (blue). (i) AP and Von Kossa staining of mesoangioblasts treated with BMP2 under osteogenic-promoting condition. Arrows point to calcified nodules. (j) Red Oil staining of mesoangioblasts treated with insulin under adipogenic-promoting condition. Scale bar in j: 50 µm for e-h; 200 µm for i; 150 µm for j.